NCT06968299View on ClinicalTrials.gov

Effect of ExoBDNF Lactic Acid Bacteria Supplement on Cognitive Functions, Sleep and Psychological

NANot yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 19, 2025

Primary Completion Date

September 30, 2025

Study Completion Date

October 30, 2025

Conditions

Cognitive Functions Perceptual DisturbancesCognitive Function AbnormalSleepPsychological

Interventions

DIETARY_SUPPLEMENT

ExoBDNF SWP-CGPA01 (Pediococcus acidilactici)Capsules

Product ingredients: microcrystalline cellulose, corn starch, SWP-CGPA01 Pediococcus acidilactici powder (1.0 x 10\^10 CFU); Capsule shell composition: HPMC (hydroxypropyl methylcellulose), pure water, titanium dioxide, gelatin.

Trial Locations (1)

Unknown

Tri-Service General Hospital, National Defense Medical Center, Taipei

All Listed Sponsors

lead

SunWay Biotech Co., LTD.

INDUSTRY

NCT06968299 - Effect of ExoBDNF Lactic Acid Bacteria Supplement on Cognitive Functions, Sleep and Psychological | Biotech Hunter | Biotech Hunter